We are live on ! Find out more
NFT

Nan Fung Trinity Portfolio holdings

AUM $1.01B
1-Year Est. Return 64.38%
This Fund
S&P 500
This Quarter Est. Return
+20.38%
1 Year Est. Return
+64.38%
3 Year Est. Return
+82.31%
5 Year Est. Return
+69.52%
10 Year Est. Return
AUM
$1B
AUM Growth
+$166M
Cap. Flow
+$99.2M
Cap. Flow %
9.9%
Top 10 Hldgs %
38.73%
Holding
76
New
17
Increased
13
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.7M
2
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$33.1M
3
GEHC icon
GE HealthCare
GEHC
+$23M
4
AMX icon
America Movil
AMX
+$21.3M
5
JD icon
JD.com
JD
+$15.7M

Top Sells

Rank Stock Value
1
EWW icon
iShares MSCI Mexico ETF
EWW
+$24.6M
2
BIDU icon
Baidu
BIDU
+$23.7M
3
ECNS icon
iShares MSCI China Small-Cap ETF
ECNS
+$22.6M
4
W icon
Wayfair
W
+$15.5M
5
DELL icon
Dell
DELL
+$14M

Sector Composition

Rank Sector Weight
1 Technology 16.66%
2 Healthcare 15.94%
3 Communication Services 12.04%
4 Consumer Discretionary 11.94%
5 Materials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
51
Target
TGT
$65.6B
$5.74M 0.57%
64,000
AKRO
52
DELISTED
Akero Therapeutics
AKRO
$5.25M 0.52%
110,650
BAH icon
53
Booz Allen Hamilton
BAH
$8.39B
$4.95M 0.49%
+49,500
New +$5.29M
IQ icon
54
iQIYI
IQ
$1.23B
$4.61M 0.46%
1,801,450
-1,875,500
-51% -$4.15M
VNO icon
55
Vornado Realty Trust
VNO
$7.41B
$3.98M 0.4%
98,100
-112,900
-54% -$4.4M
PCVX icon
56
Vaxcyte
PCVX
$7.81B
$3.76M 0.37%
104,250
KRC icon
57
Kilroy Realty
KRC
$4.52B
$3.27M 0.33%
+77,400
New +$3.05M
ABEO icon
58
Abeona Therapeutics
ABEO
$366M
$2.96M 0.3%
560,770
KURA icon
59
Kura Oncology
KURA
$800M
$2.04M 0.2%
+230,880
New +$1.65M
REPL icon
60
Replimune Group
REPL
$941M
$1.95M 0.19%
465,527
KALV
61
DELISTED
KalVista Pharmaceuticals
KALV
$1.88M 0.19%
154,522
GERN icon
62
Geron
GERN
$828M
$1.88M 0.19%
1,373,550
EXEL icon
63
Exelixis
EXEL
$13.3B
$1.41M 0.14%
34,200
-30,000
-47% -$1.21M
SRRK icon
64
Scholar Rock
SRRK
$5.67B
$1.4M 0.14%
+37,642
New +$1.32M
IDV icon
65
iShares International Select Dividend ETF
IDV
$8.45B
$987K 0.1%
+27,000
New +$972K
SPYD icon
66
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
$981K 0.1%
+22,300
New +$978K
CLYM
67
Climb Bio
CLYM
$681M
$932K 0.09%
463,654
TRVI icon
68
Trevi Therapeutics
TRVI
$2.59B
$820K 0.08%
+89,575
New +$672K
DBVT
69
DBV Technologies
DBVT
$799M
$371K 0.04%
37,095
RXRX icon
70
Recursion Pharmaceuticals
RXRX
$1.59B
$338K 0.03%
+69,323
New +$364K
ALXO icon
71
ALX Oncology
ALXO
$261M
$76.8K 0.01%
41,950
DELL icon
72
Dell
DELL
$262B
-114,085
Closed -$14M
ECNS icon
73
iShares MSCI China Small-Cap ETF
ECNS
$64.9M
-712,860
Closed -$22.6M
EWW icon
74
iShares MSCI Mexico ETF
EWW
$1.92B
-406,200
Closed -$24.6M
SLG icon
75
SL Green Realty
SLG
$3.76B
-138,700
Closed -$8.59M

Similar funds

Nan Fung Trinity's Q3 2025 Portfolio in Review

As of Q3 2025, Nan Fung Trinity held 76 positions worth $1B, up 20% from $836M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Nan Fung Trinity deployed $99.2M of net new capital in Q3 2025, opening 17 new positions and adding to 13 existing holdings. Its largest new stake was Amazon: 157,608 shares worth $34.6M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Baidu, an estimated $23.7M trimmed.

  • Nan Fung Trinity's largest Q3 2025 buy was Amazon: 157,608 shares worth $34.6M.
  • Nan Fung Trinity added most to iShares MSCI Brazil ETF in Q3 2025, an estimated $33.1M increase.
  • Nan Fung Trinity's biggest Q3 2025 reduction was Baidu, cutting an estimated $23.7M.
  • Nan Fung Trinity fully exited iShares MSCI Mexico ETF in Q3 2025, selling an estimated $24.6M.
  • Nan Fung Trinity's ten largest holdings make up 39% of its $1B portfolio in Q3 2025.
  • Nan Fung Trinity opened 17 new positions and closed 5 in Q3 2025.
  • Nan Fung Trinity's portfolio value rose 20% quarter-over-quarter to $1B.

Based on Nan Fung Trinity's 13F filing for Q3 2025, filed 4 Nov 2025.